{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:43Z","timestamp":1793442703634,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H00546"],"award-info":[{"award-number":["23H00546"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025019","name":"Support for Pioneering Research Initiated by the Next Generation","doi-asserted-by":"publisher","award":["JPMJSP2108"],"award-info":[{"award-number":["JPMJSP2108"]}],"id":[{"id":"10.13039\/501100025019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115393","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:37:04Z","timestamp":1790177824000},"page":"115393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Buffering cellular stress during mRNA delivery enables immunoregulatory interleukin-2 therapy"],"prefix":"10.1016","volume":"399","author":[{"given":"Pengwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhining","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renelyn","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Yaginuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sosuke","family":"Takasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervin","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115393_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.015","article-title":"Clinical advances of mRNA vaccines for cancer immunotherapy","volume":"6","author":"Yaremenko","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.jconrel.2026.115393_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114993","article-title":"mRNA: a promising platform for cancer immunotherapy","volume":"199","author":"Kong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115393_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300275","article-title":"Revitalizing cytokine-based cancer immunotherapy through advanced delivery systems","volume":"23","author":"Chen","year":"2023","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115393_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf115","article-title":"First-in-human phase I\/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer","volume":"30","author":"Sullivan","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2026.115393_bb0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS4218","article-title":"A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma","volume":"43","author":"Humphries","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41541-023-00760-5","article-title":"The advances of adjuvants in mRNA vaccines","volume":"8","author":"Xie","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115393_bb0035","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115393_bb0040","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115393_bb0045","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41551-025-01373-0","article-title":"Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles","volume":"9","author":"Liu","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115393_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ard-2024-225492","article-title":"What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases","volume":"83","author":"Park","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2026.115393_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115393_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101566","article-title":"Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases","volume":"33","author":"Razavi","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115393_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2015.10.132","article-title":"A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens","volume":"34","author":"Swaminathan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.115393_bb0070","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115393_bb0075","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115393_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2023.06.025","article-title":"Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax\u00ae against COVID-19 in nonhuman primates","volume":"360","author":"Zamani","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115393_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115175","article-title":"The immunostimulatory nature of mRNA lipid nanoparticles","volume":"205","author":"Sharma","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115393_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","article-title":"Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA","volume":"9","author":"Li","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115393_bb0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/15476286.2024.2333123","article-title":"mRNA vaccine designs for optimal adjuvanticity and delivery","volume":"21","author":"Mochida","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114518","article-title":"Phosphatase and tensin homolog mRNA complexed with hyaluronated lipid nanoparticles for transdermal cancer immunotherapy","volume":"390","author":"Kim","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115393_bb0105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife\u2019s edge: balancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115393_bb0110","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10238-023-01020-5","article-title":"RNA modification in mRNA cancer vaccines","volume":"23","author":"Mei","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115393_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41577-021-00608-w","article-title":"Modified uridines are the key to a successful message","volume":"21","author":"Karik\u00f3","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0120","article-title":"The pivotal role of chemical modifications in mRNA therapeutics","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0125","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.3390\/ijms252011254","article-title":"Encapsulation of dexamethasone into mRNA\u2013lipid nanoparticles is a promising approach for the development of liver-targeted anti-inflammatory therapies","volume":"25","author":"Rivero Berti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115393_bb0130","doi-asserted-by":"crossref","first-page":"27977","DOI":"10.1021\/acsnano.5c10648","article-title":"Modulating immunogenicity and Reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization","volume":"19","author":"Kawaguchi","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115393_bb0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0140","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","article-title":"Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery","volume":"3","author":"Nogueira","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2026.115393_bb0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41590-025-02105-x","article-title":"The integrated stress response pathway controls cytokine production in tissue-resident memory CD4+ T cells","volume":"26","author":"Asada","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1189\/jlb.0313153","article-title":"Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation","volume":"94","author":"Muralidharan","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0155","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.2147\/DDDT.S327378","article-title":"Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures","volume":"15","author":"Peng","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2026.115393_bb0160","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1021\/ol000173t","article-title":"On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity","volume":"2","author":"Barclay","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.jconrel.2026.115393_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0170","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41591-025-04090-y","article-title":"Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial","volume":"32","author":"Sriranjan-Rothwell","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115393_bb0175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41587-022-01510-z","article-title":"A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy","volume":"41","author":"Quijano-Rubio","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0180","first-page":"1384","article-title":"Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response","volume":"6","author":"Han","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115393_bb0185","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.ymthe.2026.01.022","article-title":"Inflammatory mediators of mRNA vaccine-induced adverse reactions in mice","volume":"34","author":"Honda","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115393_bb0190","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1038\/s41467-025-61688-z","article-title":"Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115393_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0200","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.4049\/jimmunol.142.9.3121","article-title":"Tumor necrosis factor-alpha activation of the IL-2 receptor-alpha gene involves the induction of kappa B-specific DNA binding proteins","volume":"142","author":"Lowenthal","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0205","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaci.2016.02.033","article-title":"IL-1\u03b2 enhances inflammatory TH2 differentiation","volume":"138","author":"Caucheteux","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1\u03b2 and IL-2 convert human Treg into TH17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.12966","article-title":"The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis","volume":"189","author":"Schinnerling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ni.3637","article-title":"Old dog, new tricks: IL-6 cluster signaling promotes pathogenic TH17 cell differentiation","volume":"18","author":"Quintana","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0225","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1073\/pnas.85.18.6875","article-title":"Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2","volume":"85","author":"Chouaib","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115393_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113935","article-title":"Structural stability and RNase resistance of mRNA Polyplex micelles for systemic delivery","volume":"384","author":"Dirisala","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115393_bb0235","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1002\/anie.201905203","article-title":"Bundling mRNA strands to prepare Nano-assemblies with enhanced stability towards RNase for in\u00a0vivo delivery","volume":"58","author":"Yoshinaga","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115393_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/817024","article-title":"Curcumin, a natural antioxidant, acts as a noncompetitive inhibitor of human RNase L in presence of its cofactor 2-5A in vitro","volume":"2014","author":"Gupta","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2026.115393_bb0245","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s10895-023-03474-y","article-title":"Assessing partial inhibition of ribonuclease a activity by curcumin through fluorescence spectroscopy and theoretical studies","volume":"34","author":"Sahoo","year":"2023","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.jconrel.2026.115393_bb0250","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1039\/C9PY01596E","article-title":"Curcumin\u2013polymer conjugates with dynamic boronic acid ester linkages for selective killing of cancer cells","volume":"11","author":"Pan","year":"2020","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.115393_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300601","article-title":"A curcumin-modified coordination polymers with ROS scavenging and macrophage phenotype regulating properties for efficient ulcerative colitis treatment","volume":"10","author":"Yao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115393_bb0260","doi-asserted-by":"crossref","first-page":"44072","DOI":"10.1021\/jacs.5c10972","article-title":"Lipid nanoparticle chaperone with redox-adaptive intracellular microenvironment modulation potentiates the potency of mRNA vaccines","volume":"147","author":"Yu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115393_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114047","article-title":"The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity","volume":"386","author":"Bates","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115393_bb0270","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1039\/D2BM00883A","article-title":"mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency","volume":"10","author":"Forster","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115393_bb0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0280","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1600699","article-title":"Active Caspase-1 induces plasma membrane pores that precede Pyroptotic lysis and are blocked by lanthanides","volume":"197","author":"Russo","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0285","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/cdd.2015.176","article-title":"Inflammasome-dependent IL-1\u03b2 release depends upon membrane permeabilisation","volume":"23","author":"Martin-Sanchez","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115393_bb0290","doi-asserted-by":"crossref","first-page":"2170164","DOI":"10.1080\/14686996.2023.2170164","article-title":"Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via \u03c0\u2013\u03c0 stacking-assisted micellar assembly","volume":"24","author":"Yang","year":"2023","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115393_bb0295","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s44161-025-00652-y","article-title":"Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome","volume":"4","author":"Case","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2026.115393_bb0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0305","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41467-023-37424-w","article-title":"Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells","volume":"14","author":"Inaba","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115393_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcmgh.2019.05.001","article-title":"Low-dose interleukin-2 ameliorates colitis in a preclinical humanized mouse model","volume":"8","author":"Goettel","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0315","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159406","article-title":"Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation","volume":"7","author":"Tchitchek","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.115393_bb0320","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.7150\/thno.41534","article-title":"Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways","volume":"10","author":"Lee","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115393_bb0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0330","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2026.115393_bb0335","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.febslet.2010.12.043","article-title":"Lysosomal membrane permeabilization causes oxidative stress and ferritin induction in macrophages","volume":"585","author":"Ghosh","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2026.115393_bb0340","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1074\/jbc.M109.053058","article-title":"Constitutive reactive oxygen species generation from autophagosome\/lysosome in neuronal oxidative toxicity","volume":"285","author":"Kubota","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115393_bb0345","doi-asserted-by":"crossref","first-page":"1901379","DOI":"10.1002\/adhm.201901379","article-title":"In vitro human liver model of nonalcoholic steatohepatitis by coculturing hepatocytes, endothelial cells, and Kupffer cells","volume":"8","author":"Suurmond","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115393_bb0350","article-title":"Polymer-based mRNA delivery strategies for advanced therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115393_bb0355","article-title":"Polymeric Nanocarriers with controlled chain flexibility boost mRNA delivery in vivo through enhanced structural fastening","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115393_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70002","article-title":"Polymers for mRNA Delivery","volume":"17","author":"Wang","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-0716-4562-8_18","article-title":"Synthesis of poly(amino acids) using ring opening polymerization","volume":"2909","author":"Chen","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115393_bb0370","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1039\/D4MH00325J","article-title":"Triphenylphosphonium-modified catiomers enhance in vivo mRNA delivery through stabilized polyion complexation","volume":"11","author":"Norimatsu","year":"2024","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.jconrel.2026.115393_bb0375","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1364\/OE.19.026839","article-title":"Adaptive optics for fluorescence correlation spectroscopy","volume":"19","author":"Derouard","year":"2011","journal-title":"Opt. Express"},{"key":"10.1016\/j.jconrel.2026.115393_bb0380","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2026.115393_bb0385","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2026.115393_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jconrel.2026.115393_bb0395","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2026.115393_bb0400","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2026.115393_bb0405","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2026.115393_bb0410","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41467-019-09856-w","article-title":"In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers","volume":"10","author":"Watanabe","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115393_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106632","article-title":"Isolation and purification of immune cells from the liver","volume":"85","author":"Shi","year":"2020","journal-title":"Int. Immunopharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:48:23Z","timestamp":1793440103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":83,"alternative-id":["S0168365926007972"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115393","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buffering cellular stress during mRNA delivery enables immunoregulatory interleukin-2 therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115393"}}